H.R. 9382, titled the 'Alpha-gal Allergen Inclusion Act,' proposes to amend the Federal Food, Drug, and Cosmetic Act to classify galactose-alpha-1,3-galactose (commonly known as 'alpha-gal') as a major food allergen. This amendment would require food products containing alpha-gal to be clearly labeled, thereby informing consumers of its presence. The bill specifies that alpha-gal includes ingredients derived from non-catarrhine primate mammals and red algae in the order Gigartinales. However, it excludes mammal-derived ingredients from alpha-gal-knockout mammals, as determined by the Secretary, from this classification. The proposed changes are set to take effect on January 1, 2026.
Supporters of H.R. 9382 argue that the bill is a significant step forward in protecting individuals with alpha-gal syndrome, a condition that can cause severe allergic reactions to mammalian meat products. By mandating clear labeling of alpha-gal in food products, the legislation aims to enhance consumer safety and awareness. Advocates highlight that this measure aligns with existing practices for other major food allergens, ensuring that consumers are adequately informed about potential allergens in their food.
Critics of the bill express concerns about the potential regulatory burden it may impose on food producers, particularly those who utilize mammalian-derived ingredients. They argue that the requirement to label alpha-gal could lead to increased production costs and logistical challenges in sourcing and labeling ingredients. Additionally, some industry representatives question the necessity of the legislation, suggesting that existing food safety regulations may already provide sufficient consumer protection.
The analysis of H.R. 9382, sponsored by Timothy Kennedy, reveals no direct industry overlaps between the bill's subject matter and the sponsor's top donor industries. The bill focuses on linking applications for family members in the NEXUS application process, which does not appear to be directly influenced by any of the major donor industries associated with Kennedy. While there is significant lobbying activity in related areas, such as wireless internet service providers and various healthcare associations, these do not directly correlate with the bill's content. The total lobbying amounts are substantial, but they do not create a clear conflict regarding the bill's intent or provisions. Therefore, the risk of conflict of interest is assessed as low.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| LEADING BUILDERS OF AMERICA | LEADING BUILDERS OF AMERICA | $220,000 |
| NORTH AMERICAN RENDERERS ASSOCIATION | THE RUSSELL GROUP, INC. | $30,000 |
| STM | WEINREICH STRATEGIC GROUP, INC. | $20,000 |
| INTERNATIONAL DOWNTOWN ASSOCIATION | AGORA CONSULTING, LLC | $15,000 |
| AMERICAN CULTURAL RESOURCES ASSN | AGORA CONSULTING, LLC | $15,000 |
| WIRELESS INTERNET SERVICE PROVIDERS ASSN | AGORA CONSULTING, LLC | undisclosed |
| BROWNSTEIN HYATT FARBER SCHRECK, LLP OBO MEDEXPERT INTERNATIONAL, INC. | NET CENTRIC ALLIANCE LLC | undisclosed |
| BROWNSTEIN HYATT FARBER SCHRECK, LLP OBO INVACARE AMERICA | NET CENTRIC ALLIANCE LLC | undisclosed |
| BROWNSTEIN HYATT FARBER SCHRECK, LLP OBO EPTURA, INC. | NET CENTRIC ALLIANCE LLC | undisclosed |
| BERTRAND CHAFFEE HOSPITAL | MANATT, PHELPS, AND PHILLIPS | undisclosed |
| CROUSE HEALTH | MANATT, PHELPS, AND PHILLIPS | undisclosed |
| BROWNSTEIN HYATT FARBER SCHRECK, LLP OBO WELLHIVE | NET CENTRIC ALLIANCE LLC | undisclosed |
| THE WISTAR INSTITUTE | MANATT, PHELPS, AND PHILLIPS | undisclosed |
| BROWNSTEIN HYATT FARBER SCHRECK, LLP OBO BEEP, INC. | NET CENTRIC ALLIANCE LLC | undisclosed |
| ST. BARNABAS HOSPITAL | MANATT, PHELPS, AND PHILLIPS | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Timothy Kennedy, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
